登入
選單
返回
Google圖書搜尋
Durability of Bioprosthetic Aortic Valve Replacement in Patients Under the Age of 60 Years - 1-year Follow-up from the Prospective INDURE Registry
Bart Meuris
Jean-Christian Roussel
Michael A. Borger
Matthias Siepe
Pierluigi Stefano
Günther Laufer
Thierry Langanay
Alexis Théron
Martin Grabenwöger
Konrad Binder
Philippe Demers
Renzo Pessotto
Wouter van Leeuwen
Thierry Bourguignon
Sergio Canovas
Giovanni Mariscalco
Enrico Coscioni
Francois Dagenais
Olaf Wendler
Gianluca Polvani
Matthias Eden
Beate Botta
Peter Bramlage
Ruggero De Paulis
出版
Universität
, 2023
URL
http://books.google.com.hk/books?id=B7hg0AEACAAJ&hl=&source=gbs_api
註釋
Abstract: OBJECTIVES
We report 1-year safety and clinical outcomes in patients 60 years undergoing bioprosthetic surgical aortic valve intervention.brbrMETHODSbrThe INSPIRIS RESILIA Durability Registry is a prospective, multicentre registry to assess clinical outcomes of patients 60 years. Patients with planned SAVR with or without concomitant replacement of the ascending aorta and/or coronary bypass surgery were included. Time-related valve safety, haemodynamic performance and quality of life (QoL) at 1 year were assessed.brbrRESULTSbrA total of 421 patients were documented with a mean age of 53.5 years, 76.5% being male and 27.2% in NYHA class III/IV. Outcomes within 30 days included cardiovascular-related mortality (0.7%), time-related valve safety (VARC-2; 5.8%), thromboembolic events (1.7%), valve-related life-threatening bleeding (VARC-2; 4.3%) and permanent pacemaker implantation (3.8%). QoL was significantly increased at 6 months and sustained at 1 year. Freedom from all-cause mortality at 1 year was 98.3% (95% confidence interval 97.1; 99.6) and 81.8% were NYHA I versus 21.9% at baseline. No patient developed structural valve deterioration stage 3 (VARC-3). The mean aortic pressure gradient was 12.6 mmHg at 1 year and the effective orifice area was 1.9 cm2.br